Filter
1866
Filtered Results: 1866
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
Recommendations
238
New Publications
383
Language
Document type
No document type
653
Studies & Reports
410
Guidelines
379
Manuals
219
Strategic & Response Plan
112
Training Material
52
Fact sheets
28
Situation Updates
7
Resource Platforms
4
Infographics
2
Countries / Regions
Global
161
India
36
South–East Asia Region
28
Africa
27
Western and Central Europe
27
Kenya
26
Ukraine
26
Uganda
24
South Africa
21
Ethiopia
21
Nepal
17
Ghana
17
Eastern Europe and Central Asia
16
Nigeria
14
Asia
13
Myanmar / Burma
13
Sierra Leone
12
West and Central Africa
12
East and Southern Africa
12
Bangladesh
12
Zambia
12
Syria
11
Malawi
11
Indonesia
11
Cambodia
10
Tanzania
10
Liberia
10
Rwanda
9
Middle East and North Africa
9
Western Pacific Region
8
Yemen
7
South Sudan
7
Lesotho
6
Afghanistan
6
Philippines
6
Eastern Europe
6
Thailand
5
Cameroon
5
Zimbabwe
5
Guinea
5
Mozambique
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Iran
4
Haiti
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Laos
3
Burkina Faso
3
Germany
3
Lebanon
3
Sri Lanka
3
Colombia
2
Timor Leste/ East Timor
2
China
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Jordan
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
North Korea
1
Mexico
1
Serbia
1
Turkey
1
Chile
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Namibia
1
Egypt
1
Greece
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
225
Public Health
168
Women & Child Health
136
Key Resources
136
Capacity Building
56
Pharmacy & Technologies
46
Toolboxes
Mental Health
184
HIV
151
COVID-19
148
Disability
141
TB
102
Caregiver
89
NTDs
87
Planetary Health
85
AMR
71
Rapid Response
66
Global Health Education
57
NCDs
42
Conflict
42
Pharmacy
41
Malaria
37
Health Financing Toolbox
32
Refugee
20
Ebola & Marburg
19
Specific Hazards
10
Natural Hazards
8
Social Ethics
8
Polio
7
Zika
5
Cholera
3
2.0 Rapid Response
2
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating...
This document is the national level companion to a broader document on health care facility level developed by the WHO Health Emergencies Programme for national level stakeholders
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a...
Men lag behind women regarding use of HIV services and represent the majority of individuals living with uncontrolled HIV, advanced HIV, and who experience HIV-related mortality. Men (15+) globally are less likely than women (15+) to know their HIV status (83% for men vs 91% for women), be on antire...
his document, a first of its kind, clearly sets out the standards for rehabilitation and provides guidance on building or strengthening the capacity of EMTs in this area.The importance of early rehabilitation for functional outcomes is well documented. Rehabilitation needs can pe...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The guidance document provides a set of indicators for assessing the status of development, implementation and monitoring of key policy interventions for prevention and control of NCDs and injuries. It promotes city-level evidence based decision-making processes to identify gaps and take appropriate...
These Course handouts have been designed for use by directors and trainers to aid in registering participants and evaluating trainers, and include job aids, answer sheets, forms, checklists and other tools for course participants to use during the training sessions. Items not supplied in the Course ...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
This collection of case studies on risk communication and community engagement (RCCE) from 18 different country/area level public health partners in the WHO European Region provides evidence of numerous results achieved and lessons learned since the start of the COVID-19 pandemic. RCCE has not...
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
The aim of this protocol is to support the conduct of entomological comparative efficacy assessments for vector control products and the associated non-inferiority analysis. This evidence is used to inform discussions within the guidelines development context as to whether a new vector control prod...
This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public health programmes, communit...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
